Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
Impact of the nutritional status on pulmonary function in COPD patients Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Longitudinal study of lung function in exacerbations of COPD patients during 10 years Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003
Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Psychological comorbidities in patients with COPD: Which changes can be observed after 3, 6, 9 and 12 months of an inpatient pulmonary rehabilitation (PR)? Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015
High rate of obstructive pulmonary function tests in adults below 40 Years of age in Germany Source: Annual Congress 2013 –COPD diagnosis Year: 2013
The impact of comorbidities on pulmonary rehabilitation outcomes in patients with COPD Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016
Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013
Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Burden of comorbidities and NT-proBNP concentrations in stable COPD patients Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
COPD assessment for symptoms and functional condition in pulmonary rehabilitation Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015